JulyMD Review

What JulyMD charges

• Semaglutide: $197/mo — a first month struck through from $297 under a "$100 Off First Month!" banner; the standing rate is the $297
• NAD+: $279/mo — from, per month
• NAD+: $279/mo — from, per month; priced identically to the injection
• Glutathione: $99/mo — from, per month
• Glutathione: $179/mo — from, per month

The federal letter names this seller's own address

The letter issued in September 2025 opens by citing the same web address this row tracks, and the recipient contact it lists is a mailbox on that same domain.

There is therefore no question of a similarly named company standing in for this one.

It is recorded here as the seller's letter, not a pharmacy's, because the letter says so itself.

Every state but one is an exclusion, not a coverage list

Its eligibility copy reads "Located in one of the states we service (currently every state except Mississippi)".

That names the one state it cannot reach and no others, and it is the only availability sentence published anywhere on the site.

So no all-fifty claim is credited here and no state list is recorded. Naming what you exclude is not the same sentence as listing what you serve.

Two pharmacy networks in adjacent sentences

Its terms define "the JulyMD Pharmacy Network", then ask consent to "disclose to the Bask Pharmacy Network all information provided by you".

The second name is not this brand's, and the same unedited clause appears in another seller's terms read the same week, so the two are working from a shared template.

Which network actually receives a patient's information is unresolved on the seller's own documents, and this review does not resolve it either.

What the prices carry and what they leave out

Its semaglutide page prints a first-month rate struck through from a higher standing rate under a banner announcing the discount, and both figures are recorded; the standing one is the price.

NAD+ costs the same whether bought as an injection or as a nasal spray, with no explanation of why two different forms land on one number, while glutathione differs between its two forms.

No price on the site carries a dose. A NAD+ face cream sold at a fourth price is not filed here, because the page never states how much NAD+ is in it.

FDA disclosure

JulyMD received an FDA warning letter issued September 2025. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.

How we verified this

• Read the eligibility sentence in full and recorded the single excluded state rather than converting an exclusion into a coverage claim.
• Read the promotional banner and the struck-through figure together on the semaglutide page, and filed the standing rate rather than the first-month one.
• Read the two pharmacy-network clauses in sequence in the seller's own terms and recorded both names without choosing between them.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Confirmed the federal warning letter from the letter's own opening line, which names this seller's website, and matched the recipient contact to that same domain.